Type 2 & other diabetes

Associations of Insomnia With Insulin Resistance Traits: A Cross-sectional and Mendelian Randomization Study

J Clin Endocrinol MetabPublished Cross-sectional and Mendelian randomization study

Authors' conclusion

This study provides robust evidence supporting that more frequent insomnia symptoms are associated with IR and its related traits across different angles. These findings indicate that insomnia symptoms can be served as a promising target to improve IR and prevent subsequent T2D.

Study context

Population
UK Biobank participants
Exposure
More frequent vs less frequent insomnia symptoms
Outcome
IR (triglyceride-glucose index and TG/HDL-C ratio) and related traits (glucose level, TG, HDL-C)
Methodological detailsmultivariable regression, 1-sample Mendelian randomization, 2-sample Mendelian randomization, 2-step MR mediation analysis, Bonferroni adjustment
  • Multivariable regression
  • 1-sample Mendelian randomization
  • 2-sample Mendelian randomization
  • 2-step MR mediation analysis
  • Bonferroni adjustment

Main finding

As reported in the abstract

Associations of more frequent insomnia symptoms with IR traits
Triglyceride-glucose index, multivariable regression (MVR) β
0.024, P < 2.00E-16
Triglyceride-glucose index, 1SMR β
0.343, P < 2.00E-16
TG/HDL-C ratio, MVR β
0.016, P = 1.75E-13
TG/HDL-C ratio, 1SMR β
0.445, P < 2.00E-16
TG level, MVR β
0.019 log mg/dL, P < 2.00E-16
TG level, 1SMR β
0.289 log mg/dL, P < 2.00E-16

Observational data: associations, not effects.

Further findings

2SMR validation

Similar evidence obtained using 2SMR

Proportion of insomnia–T2D association mediated by insulin resistance (IR)

Mediated by IR
25.21%
  • 2-step MR design

Original publication

Associations of Insomnia With Insulin Resistance Traits: A Cross-sectional and Mendelian Randomization Study. J Clin Endocrinol Metab. Published 16 February 2023. doi:10.1210/clinem/dgad089

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.